Global Lancing Devices And Equipment Market Major Players 2024, Forecast To 2033
16 Jan, 2024
The lancing devices and equipment market has rapidly expanded from $0.59 billion in 2023 to $0.7 billion in 2024, marking an 18.4% CAGR. Historic growth is linked to diabetes prevalence, patient convenience, home-based monitoring, and healthcare digitization. Predicted to reach $1.46 billion in 2028 at a 20.2% CAGR, the forecast period emphasizes the ongoing diabetes epidemic, advances in testing accuracy, telehealth and remote monitoring, and personalized medicine. Trends include continuous glucose monitoring (CGM) integration, non-invasive glucose monitoring, user-centered design, and sustainability and eco-friendly materials.
Global Lancing Devices And Equipment Market Key Driver
The rising prevalence of diabetes boosts the market for lancing devices and equipment. Diabetics increasingly rely on lancing devices to test blood glucose levels. The International Diabetes Federation estimates 537 million adults had diabetes in 2021, with projections reaching 783 million by 2045. This surge in diabetic patients drives the demand for lancing devices and equipment, promoting market growth.
Get A Free Sample Of The Global Lancing Devices And Equipment Market ReportGlobal Lancing Devices And Equipment Market Segments
The lancing devices and equipment market covered in this report is segmented –
1) By Type: Reusable, Disposable
2) By Product: Safety Lancets, Standard Lancets
3) By Penetration Depth: 0.8mm-1mm, 1.1mm- 1.5mm, 1.6mm-2.0mm, Other Penetration Depths
4) By End User: Hospitals and Clinics, Homecare and Home Diagnostics, Diagnostic Centres and Medical Institutions, Research and Academic Laboratories, Other End User
By Geography: The regions covered in the lancing devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions
North America was the largest region in the global lancing devices and equipment market in 2023. Western Europe was the second-largest region in the lancing devices and equipment market. The regions covered in the lancing devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Major Lancing Devices And Equipment Industry Players
Abbott laboratories, B. Braun Melsungen AG, Terumo Corporation, F. Hoffmann-La Roche AG, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Becton Dickinson and Company, Bayer AG, Medtronic plc, ARKRAY Inc., Sanofi S.A., Ypsomed Holding AG, Sarstedt AG & Co., Greiner Bio-One, HTL-STREFA S.A, Guangzhou Improve Medical Instruments Co. Ltd., UltiMed Inc., Allison Medical Inc., Artsana S.p.a., Perrigo Diabetes Care, MedExel Co. Ltd., Simple Diagnostics, Stat Medical Inc., Trividia Health, Eli Lilly and Company, Roche Diagnostics, Terumo Corporation, LifeScan, Dynarex Corporation, Dealmed Medical Supplies LLC, Advanced Diabetic Solutions, Medline Industries Inc., Owen Mumford, ARKRAY USA Inc., Nipro Diagnostics Inc., AgaMatrix Inc., Nova Biomedical, Prodigy Diabetes Care LLC, ACON Laboratories Inc.
Get The Full Global Lancing Devices And Equipment Market Report
Lancing Devices And Equipment Market Overview
Lancing devices and equipment are used to prick the skin to obtain blood samples for testing glucose levels.
Lancing Devices And Equipment Global Market Report 2023 provides data on the global lancing devices and equipment market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The lancing devices and equipment market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.